Diagnostic Potential of Plasmatic MicroRNA Signatures in Stable and Unstable Angina

Purpose We examined circulating miRNA expression profiles in plasma of patients with coronary artery disease (CAD) vs. matched controls, with the aim of identifying novel discriminating biomarkers of Stable (SA) and Unstable (UA) angina. Methods An exploratory analysis of plasmatic expression profile of 367 miRNAs was conducted in a group of SA and UA patients and control donors, using TaqMan microRNA Arrays. Screening confirmation and expression analysis were performed by qRT-PCR: all miRNAs found dysregulated were examined in the plasma of troponin-negative UA (n=19) and SA (n=34) patients and control subjects (n=20), matched for sex, age, and cardiovascular risk factors. In addition, the expression of 14 known CAD-associated miRNAs was also investigated. Results Out of 178 miRNAs consistently detected in plasma samples, 3 showed positive modulation by CAD when compared to controls: miR-337-5p, miR-433, and miR-485-3p. Further, miR-1, -122, -126, -133a, -133b, and miR-199a were positively modulated in both UA and SA patients, while miR-337-5p and miR-145 showed a positive modulation only in SA or UA patients, respectively. ROC curve analyses showed a good diagnostic potential (AUC ≥ 0.85) for miR-1, -126, and -483-5p in SA and for miR-1, -126, and -133a in UA patients vs. controls, respectively. No discriminating AUC values were observed comparing SA vs. UA patients. Hierarchical cluster analysis showed that the combination of miR-1, -133a, and -126 in UA and of miR-1, -126, and -485-3p in SA correctly classified patients vs. controls with an efficiency ≥ 87%. No combination of miRNAs was able to reliably discriminate patients with UA from patients with SA. Conclusions This work showed that specific plasmatic miRNA signatures have the potential to accurately discriminate patients with angiographically documented CAD from matched controls. We failed to identify a plasmatic miRNA expression pattern capable to differentiate SA from UA patients.

[1]  P. Fasanaro,et al.  microRNAs: Promising Biomarkers and Therapeutic Targets of Acute Myocardial Ischemia. , 2015, Current vascular pharmacology.

[2]  R. Testa,et al.  Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. , 2013, International journal of cardiology.

[3]  C. Stefanadis,et al.  MicroRNAs in the diagnosis and treatment of unstable angina. , 2013, Current Topics in Medicinal Chemistry.

[4]  S. Ghaderian,et al.  The role of microRNAs in cardiovascular disease , 2013, International journal of molecular and cellular medicine.

[5]  J. Moreno-Navarrete,et al.  Targeting the circulating microRNA signature of obesity. , 2013, Clinical chemistry.

[6]  Sankey V. Williams,et al.  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass , 2012, Journal of the American College of Cardiology.

[7]  A. Tijsen,et al.  Coronary Artery Disease CAD is caused by atherosclerosis of the coronary arteries , 2012 .

[8]  V. V. Empel,et al.  Circulating miRNAs: Reflecting or Affecting Cardiovascular Disease? , 2012, Current Hypertension Reports.

[9]  S. Fujii,et al.  Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol , 2012, Thrombosis Journal.

[10]  C. Stefanadis,et al.  The Role of microRNAs in Cardiovascular Disease , 2012 .

[11]  Zhijian Yang,et al.  Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease , 2012, Lipids in Health and Disease.

[12]  M. Capogrossi,et al.  MicroRNAs and myocardial infarction , 2012, Current opinion in cardiology.

[13]  A. Timmis,et al.  [Almanac 2011: Stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology]. , 2012, Giornale italiano di cardiologia.

[14]  E. Stępień,et al.  Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation. , 2012, Archives of medical research.

[15]  Stefanie Dimmeler,et al.  Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[16]  G. Calin,et al.  MicroRNAs in body fluids—the mix of hormones and biomarkers , 2011, Nature Reviews Clinical Oncology.

[17]  Xueqing Yu,et al.  Signature microRNA Expression Profile of Essential Hypertension and Its Novel Link to Human Cytomegalovirus Infection , 2011, Circulation.

[18]  Gang Bao,et al.  MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB , 2011, Cardiology research and practice.

[19]  D. Erlinge,et al.  Cardiospecific microRNA Plasma Levels Correlate with Troponin and Cardiac Function in Patients with ST Elevation Myocardial Infarction, Are Selectively Dependent on Renal Elimination, and Can Be Detected in Urine Samples , 2011, Cardiology.

[20]  K. Shrey,et al.  Micro RNAs: tiny sequences with enormous potential. , 2011, Biochemical and biophysical research communications.

[21]  Ugo Pastorino,et al.  MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer , 2011, Proceedings of the National Academy of Sciences.

[22]  Jason B. Nikas,et al.  ROC-supervised principal component analysis in connection with the diagnosis of diseases. , 2011, American journal of translational research.

[23]  A. Timmis,et al.  Almanac 2011: stable coronary artery disease. , 2011 .

[24]  Jan A Staessen,et al.  Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease , 2010, Circulation. Cardiovascular genetics.

[25]  C. Lenfant.  Chest pain of cardiac and noncardiac origin. , 2010, Metabolism: clinical and experimental.

[26]  Stefanie Dimmeler,et al.  Circulating MicroRNAs in Patients With Coronary Artery Disease , 2010, Circulation research.

[27]  Federica Limana,et al.  Circulating microRNAs are new and sensitive biomarkers of myocardial infarction , 2010, European Heart Journal.

[28]  Perry D Moerland,et al.  MiR423-5p As a Circulating Biomarker for Heart Failure , 2010, Circulation research.

[29]  Y. Matsuki,et al.  Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells*♦ , 2010, The Journal of Biological Chemistry.

[30]  L. Hood,et al.  Circulating microRNAs, potential biomarkers for drug-induced liver injury , 2009, Proceedings of the National Academy of Sciences.

[31]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[32]  Carl J Pepine,et al.  ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.

[33]  Carl J Pepine,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.

[34]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[35]  R Ruthazer,et al.  Missed diagnoses of acute cardiac ischemia in the emergency department. , 2000, The New England journal of medicine.